Clinical-pathological characteristics of patients assisted at the Associated Teaching Center of Medical Oncology at Soriano Departmental Hospital during its first year of operation.

DOI: https://doi.org/10.25184/anfamed2023v10n1a12
Keywords: epidemiology, neoplasms, Clinicopathological characteristics, Cancer

Abstract

Introduction: According to the Ministry of Health, cancer deaths constitute a quarter of the total deaths registered in Uruguay each year.

Objective: To identify the epidemiological profile of patients diagnosed with cancer treated at the Departmental Hospital of Soriano.

Materials and Methods: An observational, retrospective and descriptive study that included patients diagnosed with cancer attended at the Departmental Hospital of Soriano during 2022. The anonymity of the patients was maintained in the statistical analysis and approval was obtained from the Ethics Committee of the Hospital de Clínicas.

Results: A total of 113 new patients were included; 53.1% were men, with a median age at diagnosis of 69 years old. The four most frequent tumors for both sexes were: breast, prostate, lung and colorectal; the distribution by stage was as follows: Stage IV 48.6% patients; Stage III 22.5%; Stage II 26.5%; and Stage I 2.6%.  In 79.6% of the patients the diagnosis was confirmed by pathological anatomy. The time between diagnosis and first oncological treatment was ≤ 3 months for 88.2% of patients. The total number of patients with Stage IV were contacted by the Palliative Care Unit. Only 15% of the cases were discussed in the Tumor Committee.

Conclusions: The data analyzed made it possible to characterize the epidemiological profile of cancer in patients from Soriano assisted in the public sector and may contribute to the implementation of public policies aimed at prevention and, therefore, at improving patient care.

 

Downloads

Download data is not yet available.

References

1. Situación epidemiológica del Uruguay en relacion al cáncer. Incidencia del cáncer en el quinquenio 2014-2018. Tendencia de la mortalidad por cáncer hasta 2020. Mayo 2021. Comisión Honoraria de Lucha Contra el Cáncer. Registro Nacional de Cáncer. [citado: 6 de abril 2023] Disponible en: https://www.comisioncancer.org.uy/aucdocumento.aspx?311,1465
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424.
3. Kaufman CS, Shockney L, Rabinowitz B, Coleman C, Beard C, Landercasper J, et al. Quality Measures for Breast Centers (NQMBC): a robust quality tool: breast center quality measures. Ann Surg Oncol. 2010; 17:377– 85.
4. Del Turco MR, Ponti A, Bick U, Biganzoli L, Cserni G, Cutuli B et al. Quality indicators in breast cancer care. Eur J Cancer. 2010; 46:2344–56.
5. Desch CE, McNiff KK, Schneider EC, Schrag D, McClure J, Lepisto E, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol. 2008; 26:3631–7.
6. Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016; 2:330–9.
7. Vandergrift JL, Niland JC, Theriault RL, Edge SB, Wong YN, Loftus LS, et al.Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst. 2013; 105:104– 12.
8. Gagliato Dde M, Gonzalez-Angulo AM, Lei X, Theriault RL, Giordano SH, Valero V, et al. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer. J Clin Oncol. 2014; 32:735–44.
9. Chavez-MacGregor M, Clarke CA, Lichtensztajn DY, Giordano SH. Delayed initiation of adjuvant chemotherapy among patients with breast cancer. JAMA Oncol. 2015; 2:322–9.
10. Neuss MN, Desch CE, McNiff KK, Eisenberg PD, Gesme DH, Jacobson JO, et al. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative. J Clin Oncol. 2005 Sep 1;23(25):6233-9. doi: 10.1200/JCO.2005.05.948. Epub 2005 Aug 8. PMID: 16087948.
11. State Government of Victoria. Department of Health. Multidisciplinary cancer care. Literature review 2012. Victoria, Canadá: State Government of Victoria. Department of Health; 2012
12. Organización Mundial de la Salud. Control de cáncer: Aplicación de los conocimientos. Guía de la OMS para desarrollar programas eficaces. Cuidados paliativos. Ginebra, Suiza: OMS; 2007
13. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5.
14. Comisión Honoraria de Lucha contra el Cancer. Informe Anual. Periodo 2012-2016 (Fecha acceso: 20/04/2020). Disponible en: https://www.comisioncancer.org.uy/Ocultas/Cancer-de-MAMA-Mujeres--uc77
15. Barrios E.; Garau M. Cáncer: Magnitud del problema en el mundo y en Uruguay, aspectos epidemiológicos. Anales de la Facultad de Medicina 2017, 4, 9–46
16. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B.K. Humphrey L. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151 (10): 727-37, W237-42, 2009
17. Basso J, Lustemberg C, Quian J, Rosa R, Echevarría A. Guía de Práctica Clínica de Detección Temprana del Cáncer de Mama. Minist Salud Pública República Orient del Uruguay [Internet]. 2015;9–27. Available from: https://www.gub.uy/ministerio-salud-publica/comunicacion/publicaciones/guia-practica-clinica-deteccion-cancer-mama
18. Ley N° 17242 [Internet]. [cited 2021 Nov 17]. Available from: https://www.impo.com.uy/bases/leyes/17242-2000
19. Ordenanza N° 842/015 Exoneración de tasas moderadoras de mamografías en mujeres entre 50 y 69 años [Internet]. Ministerio de Salud Pública. 2021 [cited 20 November 2021]. Available from: https://www.gub.uy/ministerio-salud-publica/institucional/normativa/ordenanza-n-842015-exoneracion-tasas-moderadoras-mamografias-mujeres-entre
20. Llera AS, Abdelhay ESFW, Artagaveytia N, Daneri-Navarro A, Müller B, Velazquez C, et al. The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients. Front Oncol. 2022 Mar 22;12:835626.
21. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975-2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
22. Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, et al. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):726-9. PMID: 12163325.
23. Carter HB, Albertsen PC. Re: Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening. J Urol. 2015 Mar;193(3):1063-4; discussion 1064.
24. Sninsky JA, Shore BM, Lupu GV, Crockett SD. Risk Factors for Colorectal Polyps and Cancer. Gastrointest Endosc Clin N Am. 2022 Apr;32(2):195-213. doi: 10.1016/j.giec.2021.12.008. Epub 2022 Feb 22. PMID: 35361331.
25. Ministerio de Salud Pública Dirección General de la Salud, División Epidemiología. 2a Encuesta Nacional de Factores de Riesgo de Enfermedades Crónicas No Transmisibles. Fecha de acceso 12 de enero 2022. Disponible en https://www.gub.uy/ministerio-salud-publica/sites/ministerio-salud-publica/files/documentos/publicaciones/2DA_ENCUESTA_NACIONAL_final2_digital.pdf
26. Ministerio de Salud Pública. Guía de práctica clínica de tamizaje de cáncer colo rectal. 2018. Fecha de acceso 16 de enero 2023. Disponible en : https://www.gub.uy/ministerio-salud-publica/sites/ministerio-salud-publica/files/documentos/publicaciones/Gu%C3%ADa%20para%20el%20tamizaje%20del%20cáncer%20colo-rectal.pdf
27. Barta JA, Powell CA, Wisnivesky JP. Global Epidemiology of Lung Cancer. Ann Glob Health. 2019 Jan 22;85(1):8. doi: 10.5334/aogh.2419. PMID: 30741509; PMCID: PMC6724220.
28. Organización Mundial de la Salud. El Convenio marco para el control del tabaco. ISBN: 9243591010. 2003. Disponible en internet en: https://www3.paho.org/hq/index.php?option=com_content&view=article&id=1317:2009-who-framework-convention-on-tobacco-control-who-fctc&Itemid=0&lang=es#gsc.tab=0
Published
2023-05-12
How to Cite
Camejo, N., Strazzarino, N., Rodriguez Saenz, V., Cabrera, L., Ibarburu, J., Castillo, C., Amarillo, D., Dörner, C., & Krygier, G. (2023). Clinical-pathological characteristics of patients assisted at the Associated Teaching Center of Medical Oncology at Soriano Departmental Hospital during its first year of operation. Anales De La Facultad De Medicina, 10(1), e202. https://doi.org/10.25184/anfamed2023v10n1a12
Issue
Vol. 10 No. 1 (2023): Anales de la Facultad de Medicina
Section
Artículos originales

Copyright (c) 2023 Natalia Camejo, Noelia Strazzarino, Valeria Rodriguez Saenz, Lujan Cabrera, Joselina Ibarburu, Cecilia Castillo, Dahiana Amarillo, Carolina Dörner, Gabriel Krygier

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution 4.0 International License. that allows sharing the work as long as the initial publication in this magazine is indicated.